Literature DB >> 24024861

Case reports of PML in patients treated for psoriasis.

Ulrich Mrowietz, Kristian Reich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24024861     DOI: 10.1056/NEJMc1307680

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.

Authors:  Roberto Bomprezzi
Journal:  Ther Adv Neurol Disord       Date:  2015-01       Impact factor: 6.570

2.  The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.

Authors:  Michela Campolo; Giovanna Casili; Flavia Biundo; Rosalia Crupi; Marika Cordaro; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Antioxid Redox Signal       Date:  2017-01-27       Impact factor: 8.401

Review 3.  Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.

Authors:  Lilla Landeck; Khusru Asadullah; Adriana Amasuno; Ignasi Pau-Charles; Ulrich Mrowietz
Journal:  Arch Dermatol Res       Date:  2018-03-24       Impact factor: 3.017

Review 4.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05

5.  A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment.

Authors:  Maria-Elizabeth Baeva; Philip Boris Baev; Jill Nelson; Anna Kazimirchik; Galina Vorobeychik
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.